Managing the long-term effects of COVID-19- SIGN/ NICE/ RCGP

SIGN 161, November 2021

This guideline has been developed collaboratively by SIGN, the National Institute for Health and Care Excellence (NICE) and the Royal College of General Practitioners (RCGP).  

The guideline was developed using a ‘living’ approach, which means that targeted areas of the guideline will be continuously reviewed and updated in response to emerging evidence